Reinstitution of neuroleptic treatment with molindone in a patient with a history of neuroleptic malignant syndrome

General Hospital Psychiatry
T Slack, A Stoudemire

Abstract

The decision to reinstitute neuroleptic treatment in patients with a history of neuroleptic treatment is fraught with hazards. A case is reported in which neuroleptic treatment was successfully reintroduced with molindone after previous bouts of neuroleptic malignant syndrome (NMS) with trifluoperazine and thioridazine. Molindone may represent an alternative neuroleptic to consider in patients with a history of NMS, although all neuroleptics including clozapine and molindone may potentially precipitate this syndrome.

References

Dec 1, 1979·Psychosomatics·R A Bernstein
Apr 1, 1988·The Journal of Nervous and Mental Disease·V L Susman, G Addonizio
Aug 1, 1986·The Journal of Nervous and Mental Disease·H G PopeC E Fulwiler
May 1, 1987·Medical Toxicology·C Harpe, A Stoudemire
Oct 1, 1987·Journal of Clinical Psychopharmacology·V L Susman, G Addonizio
Nov 1, 1986·Journal of Adolescent Health Care : Official Publication of the Society for Adolescent Medicine·J M Diamond, D D Hayes
Jan 1, 1985·International Journal of Psychiatry in Medicine·T ClarkS Dubin
Jul 18, 1985·The New England Journal of Medicine·B H Guzé, L R Baxter
May 1, 1981·The Journal of Nervous and Mental Disease·M ToruK Sugano

❮ Previous
Next ❯

Citations

Jan 1, 1992·Journal of Child Psychology and Psychiatry, and Allied Disciplines·K D Gadow
Jan 30, 2002·Psychosomatics·R A PhilibertC Carney-Doebbeling
Dec 17, 2010·Expert Review of Neurotherapeutics·Hazem Shoirah, Hesham M Hamoda
Aug 1, 1990·The British Journal of Psychiatry : the Journal of Mental Science·A M Kellam
Dec 4, 2001·The Journal of ECT·J A van WaardeR C van der Mast
Nov 2, 1999·The Australian and New Zealand Journal of Psychiatry·J N Trollor, P S Sachdev

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.